Securities

  • January 20, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court wrapped up last week with a mix of deal litigation, governance fights and disclosure battles, including a proposed settlement over a contested medical device sale, a merits dismissal tied to a $2 billion biotech exit and dueling lawsuits over Paramount Skydance's pursuit of Warner Bros. Discovery.

  • January 16, 2026

    Law360 Names Practice Groups Of The Year

    Law360 would like to congratulate the winners of its Practice Groups of the Year awards for 2025, which honor the attorney teams behind litigation wins and significant transaction work that resonated throughout the legal industry this past year.

  • January 17, 2026

    Up Next At High Court: Fed Firing & Gun 'Vampire Rules'

    The Supreme Court will begin a short argument week Tuesday, during which the justices will consider President Donald Trump's authority to fire a Democratic Federal Reserve governor over allegations of mortgage fraud, as well as the ability for states to presumptively bar gun owners from carrying firearms onto private property open to the public unless the property owner explicitly allows it. 

  • January 16, 2026

    SEC Fines Adviser Over Black Rifle Coffee SPAC Deal Conflict

    Engaged Capital LLC was fined $200,000 by the U.S. Securities and Exchange Commission and agreed to a censure Friday over allegations the investment adviser failed to disclose conflicts of interest related to a special purpose acquisition company merger with Black Rifle Coffee Co. in 2022.

  • January 16, 2026

    OCC's Gould Takes Aim At Resolution Planning 'Industry'

    A top federal regulator called Friday for a sweeping rethink of rules intended to ensure big, complex banks can be safely wound down in a crisis, including potentially ending requirements to file so-called living wills with the Federal Deposit Insurance Corp.

  • January 16, 2026

    Stock Buyback Ban Could Shrink Defense Industrial Base

    The Trump administration's move to bar defense contractors from buying back their stock or paying shareholder dividends if they are underperforming on their contracts could make companies reconsider working with the U.S. government and counteract the administration's stated goals.

  • January 16, 2026

    SEC Secures $39M Orders Wrapping Fla. Investor Fraud Suit

    The U.S. Securities and Exchange Commission has gotten final judgments totaling nearly $39 million to wrap up claims that a Florida hedge fund manager, associated entities and their owner defrauded would-be investors by concealing self-dealing and misappropriation.

  • January 16, 2026

    SEC Fines Biopharma Co. Execs Over Hidden FDA Findings

    Former executives of Spero Therapeutics will pay over $187,000 to settle the U.S. Securities and Exchange Commission's claims they downplayed the likelihood that the U.S. Food and Drug Administration would reject the biopharmaceutical company's new drug application in 2022, the commission said on Friday.

  • January 16, 2026

    SEC Fines 'Cash Flow King' Podcaster $3M For Ponzi Scheme

    A podcast host dubbed the "Cash Flow King" will pay $3.3 million to settle claims that he ran a multiyear Ponzi scheme that cheated investors out of $11 million through bogus real estate investments, the U.S. Securities and Exchange Commission announced Friday.

  • January 16, 2026

    Lifecore Investors Ink $3.8M Deal In Accounting Controls Suit

    Biotech company Lifecore Biomedical Inc. has reached a $3.8 million deal with its investors to end their claims the company had weak controls over its financial reporting, impairing its ability to remain compliant with Nasdaq listing requirements and causing share declines.

  • January 16, 2026

    6th Circ. Revives Biomed Co. Investor's Suit Over Stock Sale

    The Sixth Circuit has ruled that a man who sold his stock in a biomedical research company just before being told the company planned to pursue private equity financing can bring his breach of contract and fiduciary duty claims, reversing a lower court's ruling granting summary judgment to the biomedical company.

  • January 16, 2026

    $29M Deal In Boeing Supplier Fraud Suit Gets Final OK

    A New York federal judge on Friday approved a $29 million deal to close out a suit alleging that Spirit AeroSystems Holdings Inc. misled investors by failing to disclose pervasive quality problems and a documented history of supplying its chief customer, The Boeing Co., with defective plane parts.

  • January 16, 2026

    SIFMA Presses SEC To Reverse Nasdaq Fee Hike

    The Securities Industry and Financial Markets Association is urging the U.S. Securities and Exchange Commission to force Nasdaq and other exchanges to stop collecting new fees that the organization argues were allowed to go live with little detail as to why they were necessary or how they comply with the law and past SEC guidance.

  • January 16, 2026

    Acadia Investors Get Initial OK For $179M Settlement

    Acadia Healthcare Co. Inc. investors have received the first OK from a Tennessee federal judge for a $179 million settlement in a class action alleging the company misled them about the strength of its U.K. operations.

  • January 16, 2026

    Pomerantz To Lead Biohaven Investors' FDA Approval Suit

    Pomerantz LLP will lead a proposed class of investors accusing biopharmaceutical company Biohaven Ltd. of overstating the odds that two of its product candidates would receive regulatory approval, a Connecticut judge said Friday.

  • January 16, 2026

    Judge Yanks $41M Atty Fee Award In SPAC Merger Suit

    A Texas federal judge has rescinded an attorney fee award of over $41 million to Robbins Geller Rudman & Dowd LLP, Labaton Keller Sucharow LLP and Entwistle & Cappucci LLP after the firms became engaged in a dispute over the amount of work done and the allocation of fees, among other things.

  • January 16, 2026

    7th Circ. Won't Revive Investment Cos.' VIX-Fix Claims

    The Seventh Circuit on Thursday affirmed the dismissal of two investment companies' volatility index manipulation claims against Barclays, Morgan & Stanley Co. and other financial institutions, agreeing with a lower court that one lacked standing and the other missed a statutory deadline.

  • January 16, 2026

    High Court Takes Up Intel Workers' Bid To Revive 401(k) Suit

    The U.S. Supreme Court agreed Friday to hear Intel workers' challenge to a Ninth Circuit decision backing an end to their proposed class action alleging 401(k) mismanagement, a case that gives the justices a chance to clarify the pleading standards for retirement fund underperformance. 

  • January 16, 2026

    Insurer Says Other Carrier Owes $23M For Old Policy Claims

    Sparta Insurance Co. said the former parent of an insurer it acquired reneged on its contractual obligations to handle and pay claims under policies issued before the acquisition, telling a Massachusetts federal court that it is owed more than $23 million in settlement payments, attorney fees and other costs.

  • January 15, 2026

    NCAA Urges Feds, States To Rein In College Sports Wagers

    The NCAA has urged a federal regulator to suspend prediction market trades based on college sports until appropriate safeguards are in place and called on state gambling commissions to restrict certain types of wagers, saying it knows they are being manipulated.

  • January 15, 2026

    SEC Says Healthcare Exec Misspent $10.6M In Investor Funds

    The U.S. Securities and Exchange Commission on Thursday accused a healthcare company CEO of misappropriating over $10 million from investors by falsely claiming the funds would be used to develop cancer screening and treatment technology when in fact they were spent on credit card debt, luxury vehicles and strip club visits.

  • January 15, 2026

    Getty Loses 2nd Circ. Bid Over $88M Stock Sale Breach Order

    A divided Second Circuit on Thursday upheld a ruling requiring Getty Images to pay out nearly $88 million to investors who said they were blocked from purchasing shares in the company once it became public, finding Getty breached a contract promising the investors those shares.

  • January 15, 2026

    Musk Slams SEC's 'Premature' Bid For Twitter Buy-Up Win

    The U.S. Securities and Exchange Commission shouldn't be handed an early win on its claims Elon Musk didn't make timely disclosures of his stake in Twitter when the regulator hasn't yet produced discovery in the matter, the tech billionaire has argued.

  • January 15, 2026

    Dechert Adds Ex-NYC Deputy Mayor To Co-Lead Trial Practice

    Dechert LLP announced Thursday that it has hired veteran trial lawyer Randy Mastro, who previously served as former New York City Mayor Eric Adams' first deputy, as a partner and co-chair of the firm's securities and complex litigation practice.

  • January 15, 2026

    Ex-CEO Of COVID Vax Maker Accused Of Insider Trading

    New York Attorney General Letitia James on Thursday sued the former CEO of healthcare contractor Emergent BioSolutions Inc., alleging insider trading amid troubles manufacturing a COVID-19 vaccine, while signing a $900,000 settlement with the company over its approval of an executive trading plan.

Expert Analysis

  • Banking M&A Outlook Reflects Favorable Regulatory Climate

    Author Photo

    The banking mergers and acquisitions environment is starting 2026 with a rare alignment of favorable market conditions and a more permissive regulatory atmosphere, creating a clear window for banks to pursue transformative combinations and shape the competitive landscape, say attorneys at Reed Smith.

  • ERISA Litigation Trends To Watch With 2025 In The Rearview

    Author Photo

    There were significant developments in Employee Retirement Income Security Act litigation in 2025, including plaintiffs pushing the bounds of sponsor and fiduciary liability and defendants scoring district court wins, and although the types of claims might change, ERISA litigation will likely be just as active in 2026, say attorneys at Groom Law.

  • 2025's Defining AI Securities Litigation

    Author Photo

    Three securities litigation decisions from 2025 — involving General Motors, GitLab and Tesla — offer a preview of how courts will assess artificial intelligence-related disclosures, as themes such as heightened regulatory scrutiny and risk surrounding technical claims are already taking shape for the coming year, say attorneys at Cooley.

  • Series

    Mass. Banking Brief: All The Notable Legal Updates In Q4

    Author Photo

    Among the most significant developments on the banking regulation front in Massachusetts last quarter, Attorney General Andrea Joy Campbell announced her bid for reelection, and the state Division of Banks continued its fintech focus by finalizing rules implementing a new money transmitter law, say attorneys at Nutter.

  • Series

    Muay Thai Makes Me A Better Lawyer

    Author Photo

    Muay Thai kickboxing has taught me that in order to win, one must stick to one's game plan and adapt under pressure, just as when facing challenges by opposing counsel or judges, says Mark Schork at Feldman Shepherd.

  • Series

    Law School's Missed Lessons: Intentional Career-Building

    Author Photo

    A successful legal career is built through intention: understanding expectations, assessing strengths honestly and proactively seeking opportunities to grow and cultivating relationships that support your development, say Erika Drous and Hillary Mann at Morrison Foerster.

  • How Shareholder Activism Fared In 2025

    Author Photo

    2025 was a turbulent yet transformative year in shareholder activism, and there are several key takeaways to help companies prepare for a 2026 that is shaping up to be even more lively, including increased focus on retail investors and the use of social media as a tool, say attorneys at Sidley.

  • Justices' Separation-Of-Powers Revamp May Hit States Next

    Author Photo

    The U.S. Supreme Court's 2024 decision in U.S. Securities and Exchange Commission v. Jarkesy quietly laid the groundwork for an expansion of the court's separation-of-powers agenda beyond the federal level, but regulated parties and state and local governments alike can act now to anticipate Jarkesy's eventual wider application, say attorneys at Troutman.

  • Preparing For Congressional Investigations In A Midterm Year

    Author Photo

    2026 will be a consequential year for congressional oversight as the upcoming midterm elections may yield bolder investigations and more aggressive state attorneys general coalitions, so companies should consider adopting risk management measures to get ahead of potential changes, say attorneys at Morgan Lewis.

  • Key Trends Shaping ESG And Sustainability Law In 2026

    Author Photo

    2025 saw a chaotic regulatory landscape and novel litigation around environmental, social and governance issues and sustainability — and 2026, while perhaps more predictable, will likely be no less challenging, with more lawsuits and a regulatory tug-of-war complicating compliance for global companies, say attorneys at Crowell.

  • How Bank M&A Prospects Brightened In 2025

    Author Photo

    Even with less-than-ideal macroeconomic conditions in 2025, federal banking regulators' shift away from procedural concerns to focus more on core financial risks boosted M&A in several key ways, including shorter review timelines and increased interest in de novo charters, say attorneys at Arnold & Porter.

  • 3 Securities Litigation Trends To Watch In 2026

    Author Photo

    Pending federal appellate cases suggest that 2026 will be a significant year for securities litigation, with long-standing debates about class certification, new questions about the risks and value of artificial intelligence features, and private plaintiffs' growing role in cryptocurrency enforcement likely to be major themes, say attorneys at Willkie.

  • 4 Developments That Defined The 2025 Ethics Landscape

    Author Photo

    The legal profession spent 2025 at the edge of its ethical comfort zone as courts, firms and regulators confronted how fast-moving technologies and new business models collide with long-standing professional duties, signaling that the profession is entering a period of sustained disruption that will continue into 2026, says Hilary Gerzhoy at HWG Law.

  • Navigating AI In The Legal Industry

    Author Photo

    As artificial intelligence becomes an increasingly integral part of legal practice, Law360 guest commentary this year examined evolving ethical obligations, how the plaintiffs bar is using AI to level the playing field against corporate defense teams, and the attendant risks of adoption.

  • Regulatory Rollback And Lingering Limbo: The CFPB In 2025

    Author Photo

    The Consumer Financial Protection Bureau has implemented significant changes since President Donald Trump took office in January, including dismissing actions with prejudice, withdrawing guidance and rescinding rules, casting the bureau in uncertain light heading into 2026, say attorneys at Mayer Brown.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Securities archive.